Sooma Oy secures €1 million in investment, supported by a €250,000 grant from Business Finland, to advance its innovative drug-free therapy for depression.

Target Information

Sooma Oy is a Finnish startup that specializes in the development of non-invasive brain stimulation devices designed to treat neurological and psychiatric disorders. Founded in 2013, the company has established a strong advisory board with significant expertise in medical technology and healthcare. The team has actively collaborated with leading experts in psychiatry and clinical neurophysiology to create innovative solutions aimed at improving the treatment of depression and chronic pain.

The company’s primary therapy modulates neuronal activation in the brain's frontal areas, ensuring a quicker recovery from conditions compared to traditional antidepressant medications. Notably, the therapy is devoid of serious or systemic side effects, rendering it a safer and more effective option, especially in situations where pharmaceuticals may not be suitable. Patients can administer the pain-free treatment at home, and approximately 60% of those who complete a 30-minute daily session for three weeks report a positive response, with over 20% achieving complete remission, even in cases of severe depression.

Industry Overview in Finland

The mental health treatment sector in Finland is undergoing significant transformation, driven by advancements in technology and an increasing recognition of the urgent need for innovative treatment solutions. Mental health challenges